Element Biosciences is a company in the life sciences industry that focuses on genetic analysis methodology. Element Biosciences was founded in 2017 and is headquartered in San Diego, CA. The company provides access to advanced biological tools that strive to enable researchers to accelerate scientific discoveries. Specifically, Element Biosciences develops innovative DNA sequencing and multi-omics technology for biosciences research. The company's proprietary technology is called the AVITI system, and it offers high-quality sequencing intending to be at a lower cost than alternative methods.

Register for Details

For more details on financing and valuation for Element Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Element Biosciences

Forge green plus iconForge green minus icon

Is Element Biosciences a publicly traded company?

Element Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

Will Element Biosciences go IPO?

Element Biosciences has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

Forge green plus iconForge green minus icon

What is Element Biosciences's IPO price?

The IPO price for Element Biosciences will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Element Biosciences pre-IPO?

Element Biosciences is privately held company and is not publicly traded, therefor investing in Element Biosciences pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my Element Biosciences shares?

To determine the value of your Element Biosciences shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Element Biosciences shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell Element Biosciences before it goes public?

Yes, you can seek to sell shares in Element Biosciences while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is Element Biosciences's funding to date?

Element Biosciences has raised $684.92MM to date.
Forge green plus iconForge green minus icon

When was Element Biosciences founded?

Element Biosciences was founded in 2017.

Who are Element Biosciences's major investors?

Wellington Management
Venrock
Meritech Capital Partners
Ra Capital Management
Fidelity Management & Research
T. Rowe Price
Morgan Stanley
Foresite Capital
Janus Henderson Investors
Logos Capital
Alexandria Venture Investments
Samsung Electronics
Fusion Fund
JS Capital Management

Element Biosciences funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
7/11/2024

Series D and D-1

$277MM raised $XXX.XX $XXX.XX
6/29/2021

Series C

$277.52MM raised $XXX.XX $XXX.XX
1/9/2020

Series B

$110.3MM raised $XXX.XX $XXX.XX
6/18/2019

Series A

$15MM raised $XXX.XX $XXX.XX
9/11/2017

Series Seed

$5.11MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.